Clinical and other possible prognostic factors related to outcome 12 weeks after CVST in 59 patients

Neurological signs and symptomsn%Poor outcome (n=10)Good outcome (n=49)p Value (χ2 or Fisher's exact)
 Recent headache56/59959470.43
 Focal deficits1-151 27/59465221.0
 Paresis1-150 20/50403170.38
 Dysphasia1-150 11/5022290.30
 Visuospatial disorder1-150 4/509130.35
 Homonymous hemianopia1-150 3/506031.0
 Seizures28/59475231.0
 Generalised seizures22/59374181.0
 Focal seizures only6/5910151.0
 Papilloedema1-150 23/56415180.25
 Impaired consciousness (GCS<14)23/5939815<0.01
 Coma (GCS⩽8)9/591554<0.01
 Isolated intracranial hypertension12/59200120.10
 Transient neurological symptoms (TIA-like episodes)8/5914171.0
 Brain stem/cerebellar signs1-150 6/5012061.0
 Visual impairment1-150 5/5010140.42
Other possible prognostic factors:
 Age>33 y29/59497220.18
 Diagnostic delay⩽10 days35/59598270.18
 Any coagulation disorder1-150 19/52371180.64
 Puerperium7/5912070.59
 Cerebral haemorrhage (CT/MRI)29/5949920<0.01
 Erythrocytes in CSF1-150 12/24501111.0
 Delta sign on CT18/57321170.15
 Involvement superior sagittal sinus50/598510400.33
 Involvement straight sinus17/59295120.13
 Treatment with nadroparin (high dose)30/59514260.51
  • GCS=Glasgow coma score.

  • 1-150 Could not be assessed in the remaining patients.

  • 1-151 Signs that could not be assessed were scored negative.